Three non-invasive Treatment Options for superficial basal cell carcinoma: PDT vs. imiquimod vs. 5-fluorouracil
Phase 4
Recruiting
- Conditions
- basal cell carcinoma10040900skin cancer
- Registration Number
- NL-OMON31670
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 600
Inclusion Criteria
All patients with a primary (no previous treatment) histopathologically confirmed diagnosis of one or more sBCCs aged between 18 and 80 years old.
Exclusion Criteria
Patients using immunosuppressive drugs, patients with genetic skin cancer disorders, location in the H-zone or the hairy head, earlier treatments at the same site and pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Outcome measures: The primary outcome measure is treatment failure within 12<br /><br>months after treatment. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcome measures are degree of pain experienced during treatment,<br /><br>compliance with treatment, side effects of treatment, patient preferences and<br /><br>health care costs. </p><br>